![]() |
|
|
Vol. 30, Issue 6, 616-625, June 2002
Department of Pharmacology and Physiology (H.B.M.L., D.M.K.,
M.W.A.) and Department of Laboratory Animal Medicine (R.B.B.),
University of Rochester Medical Center, Rochester, New York;
Division of Molecular Medicine, John Curtin School of Medical Research,
Canberra, Australia (P.G.B.)
Glutathione transferase zeta (GSTZ1-1) catalyzes the
biotransformation of a range of
-haloacids, including dichloroacetic acid (DCA), and the penultimate step in the tyrosine degradation pathway. DCA is a rodent carcinogen and a common drinking water contaminant. DCA also causes multiorgan toxicity in rodents and dogs.
The objective of this study was to determine the expression and
activities of GSTZ1-1 in rat tissues with maleylacetone and chlorofluoroacetic acid as substrates. GSTZ1-1 protein was detected in
most tissues by immunoblot analysis after immunoprecipitation of
GSTZ1-1 and by immunohistochemical analysis; intense staining was
observed in the liver, testis, and prostate; moderate staining was
observed in the brain, heart, pancreatic islets, adrenal medulla, and
the epithelial lining of the gastrointestinal tract, airways, and
bladder; and sparse staining was observed in the renal juxtaglomerular regions, skeletal muscle, and peripheral nerve tissue. These patterns of expression corresponded to GSTZ1-1 activities in the different tissues with maleylacetone and chlorofluoroacetic acid as substrates. Specific activities ranged from 258 ± 17 (liver) to 1.1 ± 0.4 (muscle) nmol/min/mg of protein with maleylacetone as substrate and
from 4.6 ± 0.89 (liver) to 0.09 ± 0.01 (kidney) nmol/min/mg of protein with chlorofluoroacetic acid as substrate. Rats given DCA
had reduced amounts of immunoreactive GSTZ1-1 protein and activities
of GSTZ1-1 in most tissues, especially in the liver. These findings
indicate that the DCA-induced inactivation of GSTZ1-1 in different
tissues may result in multiorgan disorders that may be associated with
perturbed tyrosine metabolism.
This article has been cited by other articles:
![]() |
C. E.L. Lim, K. I. Matthaei, A. C. Blackburn, R. P. Davis, J. E. Dahlstrom, M. E. Koina, M.W. Anders, and P. G. Board Mice Deficient in Glutathione Transferase Zeta/Maleylacetoacetate Isomerase Exhibit a Range of Pathological Changes and Elevated Expression of Alpha, Mu, and Pi Class Glutathione Transferases Am. J. Pathol., August 1, 2004; 165(2): 679 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Thomson, A. L. Bigley, J. R. Foster, I. R. Jowsey, C. R. Elcombe, T. C. Orton, and J. D. Hayes Tissue-specific Expression and Subcellular Distribution of Murine Glutathione S-transferase Class Kappa J. Histochem. Cytochem., May 1, 2004; 52(5): 653 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. M. Lantum, J. Cornejo, R. H. Pierce, and M. W. Anders Perturbation of Maleylacetoacetic Acid Metabolism in Rats with Dichloroacetic Acid-Induced Glutathione Transferase Zeta Deficiency Toxicol. Sci., July 1, 2003; 74(1): 192 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. M. Lantum, R. B. Baggs, D. M. Krenitsky, and M. W. Anders Nephrotoxicity of Chlorofluoroacetic Acid in Rats Toxicol. Sci., December 1, 2002; 70(2): 261 - 268. [Abstract] [Full Text] [PDF] |
||||